TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 19)

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 MARKET SCOPE

1.3.1 MARKETS COVERED

1.3.2 YEARS CONSIDERED FOR THE STUDY

1.4 CURRENCY USED FOR THE STUDY

1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 22)

2.1 RESEARCH DATA

2.1.1 SECONDARY DATA

2.1.1.1 Secondary sources

2.1.2 PRIMARY DATA

2.2 MARKET ESTIMATION METHODOLOGY

2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION

2.2.2 PROCEDURE-BASED MARKET ESTIMATION

2.2.3 PRIMARY RESEARCH VALIDATION

2.3 DATA TRIANGULATION

2.4 RESEARCH ASSUMPTIONS

2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 31)

4 PREMIUM INSIGHTS (Page No. - 36)

4.1 SEPSIS DIAGNOSTICS: MARKET OVERVIEW

4.2 SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY

4.3 GEOGRAPHIC ANALYSIS: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT AND REGION

4.4 APAC: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY AND END USER

4.5 SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN

4.6 GEOGRAPHIC SNAPSHOT OF THE SEPSIS DIAGNOSTICS MARKET

5 MARKET OVERVIEW (Page No. - 40)

5.1 INTRODUCTION

5.2 MARKET DINAMICS

5.2.1 DRIVERS

5.2.1.1 High incidence of sepsis

5.2.1.2 Rising incidence of hospital-acquired infections

5.2.1.3 Growing funding for sepsis-related research

5.2.2 RESTRAINTS

5.2.2.1 Unfavorable reimbursement scenario

5.2.2.2 High cost of automated diagnostic devices

5.2.3 OPPORTUNITIES

5.2.3.1 Development of rapid diagnostic/POC techniques for early sepsis diagnosis

5.2.3.2 Evolution of novel biomarkers for sepsis diagnosis

5.2.4 CHALLENGES

5.2.4.1 Lack of standard protocols and awareness

5.2.4.2 Shortage of skilled healthcare professionals

6 SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY (Page No. - 46)

6.1 INTRODUCTION

6.2 BLOOD CULTURE

6.2.1 BLOOD CULTURE HOLDS THE LARGEST SHARE OF THE TECHNOLOGY MARKET

6.3 IMMUNOASSAYS

6.3.1 PRODUCT DEVELOPMENT EFFORTS BY MAJOR PLAYERS HAVE ENSURED DEMAND FOR IMMUNOASSAYS

6.4 MOLECULAR DIAGNOSTICS

6.4.1 POLYMERASE CHAIN REACTION

6.4.1.1 PCR holds the largest share of the molecular diagnostics market

6.4.2 MICROARRAYS

6.4.2.1 Simultaneous analysis capabilities, accuracy, and rapidity have driven the use of microarrays

6.4.3 PEPTIDE NUCLEIC ACID-FLUORESCENT IN SITU HYBRIDIZATION

6.4.3.1 PNA-FISH kits allow for the rapid diagnosis of BSIs

6.4.4 SYNDROMIC PANEL-BASED TESTING

6.4.4.1 High costs and accuracy issues have affected test adoption

6.5 FLOW CYTOMETRY

6.5.1 LACK OF STANDARDIZED PROTOCOLS IS A KEY RESTRAINT IN THIS MARKET SEGMENT

6.6 MICROFLUIDICS

6.6.1 GROWING ADOPTION OF ADVANCED & RAPID TESTING WILL FAVOR MARKET GROWTH IN THIS SEGMENT

6.7 BIOMARKERS

6.7.1 DESPITE POTENTIAL, NO SINGLE IDEAL BIOMARKER HAS BEEN IDENTIFIED FOR SEPSIS DIAGNOSTICS

7 SEPSIS DIAGNOSTICS MARKET, BY PRODUCT (Page No. - 71)

7.1 INTRODUCTION

7.2 BLOOD CULTURE MEDIA

7.2.1 BLOOD CULTURE MEDIA DOMINATE THE PRODUCTS MARKET

7.3 ASSAYS & REAGENTS

7.3.1 INCREASING AWARENESS HAS DRIVEN THE USE OF ASSAYS & REAGENTS

7.4 INSTRUMENTS

7.4.1 MARKET IS CHARACTERIZED BY A SHIFT FROM TRADITIONAL & MANUAL INSTRUMENTS TO AUTOMATED SYSTEMS

7.5 SOFTWARE

7.5.1 RISING USE OF AUTOMATED INSTRUMENTS WILL ENSURE DEMAND FOR SOFTWARE

8 SEPSIS DIAGNOSTICS MARKET, BY METHOD (Page No. - 76)

8.1 INTRODUCTION

8.2 CONVENTIONAL DIAGNOSTICS

8.2.1 CONVENTIONAL DIAGNOSTICS HOLDS LARGEST MARKET SHARE

8.3 AUTOMATED DIAGNOSTICS

8.3.1 AUTOMATED DIAGNOSTICS SEGMENT TO GROW AT THE HIGHEST CAGR

9 SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN (Page No. - 80)

9.1 INTRODUCTION

9.2 BACTERIAL SEPSIS

9.2.1 GRAM-NEGATIVE BACTERIAL SEPSIS

9.2.1.1 Gram-negative bacteria cause ~50% of sepsis infections

9.2.2 GRAM-POSITIVE BACTERIAL SEPSIS

9.2.2.1 Cases of sepsis caused by gram-positive bacteria have risen in recent years

9.3 FUNGAL SEPSIS

9.3.1 FUNGEMIA IS THE SECOND-BIGGEST CAUSE OF BLOODSTREAM INFECTIONS

9.4 OTHER PATHOGENS

10 SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE (Page No. - 86)

10.1 INTRODUCTION

10.2 LABORATORY TESTS

10.2.1 LABORATORY TESTS ARE THE MOST COMMON AND PREFERRED MODE OF TESTING

10.3 POINT-OF-CARE TESTS

10.3.1 RAPIDITY AND CONVENIENCE HAVE DRIVEN DEMAND FOR POC TESTS

11 SEPSIS DIAGNOSTICS MARKET, BY END USER (Page No. - 90)

11.1 INTRODUCTION

11.2 HOSPITALS

11.2.1 HOSPITALS HOLD THE LARGEST SHARE OF THE SEPSIS DIAGNOSTICS MARKET

11.3 PATHOLOGY & REFERENCE LABORATORIES

11.3.1 INDEPENDENT LABORATORIES OFFER AFFORDABILITY AS WELL AS THE BENEFITS OF BUNDLED SERVICES

11.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES

11.4.1 GOVERNMENT SUPPORT AND RISING AWARENESS HAVE ENSURED DEMAND FOR MARKET PRODUCTS IN THIS SEGMENT

12 SEPSIS DIAGNOSTICS MARKET, BY REGION (Page No. - 94)

12.1 INTRODUCTION

12.2 NORTH AMERICA

12.2.1 US

12.2.1.1 US is the largest market for sepsis diagnostics

12.2.2 CANADA

12.2.2.1 Growing availability of sepsis diagnostic products to support market growth in Canada

12.3 EUROPE

12.3.1 GERMANY

12.3.1.1 Germany accounted for the largest share of the European market

12.3.2 FRANCE

12.3.2.1 High incidence and rising awareness have supported the demand for sepsis diagnostics in France

12.3.3 UK

12.3.3.1 Government support and rising awareness are key drivers in the UK

12.3.4 ITALY

12.3.4.1 Sluggish growth in the Italian healthcare sector in the last few years to restrain the market growth

12.3.5 SPAIN

12.3.5.1 Rising sepsis incidence to drive market growth in Spain

12.3.6 REST OF EUROPE

12.4 ASIA PACIFIC

12.4.1 JAPAN

12.4.1.1 Significant growth in pneumonia and infectious disease incidence to support market growth in Japan

12.4.2 CHINA

12.4.2.1 Healthcare infrastructure improvements to support market growth in China

12.4.3 INDIA

12.4.3.1 Increasing patient population and rising number of surgical procedures are key growth drivers in India

12.4.4 AUSTRALIA

12.4.4.1 Increasing number of sepsis treatment procedures indicates growth potential in the Australian market

12.4.5 SOUTH KOREA

12.4.5.1 Rising healthcare spending supports market growth in South Korea

12.4.6 REST OF ASIA PACIFIC

12.5 LATIN AMERICA

12.5.1 BRAZIL

12.5.1.1 Brazil accounted for the largest share of the LATAM market

12.5.2 MEXICO

12.5.2.1 Rising medical tourism to support market growth in Mexico

12.5.3 REST OF LATIN AMERICA

12.6 MIDDLE EAST & AFRICA

12.6.1 HIGH CONSUMPTION OF IMMUNE SYSTEM-SUPPRESSING MEDICATIONS IS DRIVING SEPSIS OCCURRENCE

13 COMPETITIVE LANDSCAPE (Page No. - 135)

13.1 OVERVIEW

13.2 MARKET SHARE ANALYSIS

13.3 COMPETITIVE SCENARIO

13.3.1 PRODUCT LAUNCHES AND APPROVALS, 2016�2020

13.3.2 PARTNERSHIPS AND COLLABORATIONS, 2016�2020

13.3.3 MERGERS AND ACQUISITIONS, 2016�2020

13.3.4 MARKET EXPANSION, 2016�2020

13.4 COMPETITIVE LEADERSHIP MAPPING

13.4.1 VISIONARY LEADERS

13.4.2 INNOVATORS

13.4.3 DYNAMIC DIFFERENTIATORS

13.4.4 EMERGING COMPANIES

14 COMPANY PROFILES (Page No. - 141)

(Business Overview, Products Offered, Recent Developments, MnM View)*

14.1 BIOM�RIEUX

14.2 BECTON, DICKINSON AND COMPANY

14.3 DANAHER

14.4 T2 BIOSYSTEMS

14.5 LUMINEX

14.6 ROCHE DIAGNOSTICS

14.7 THERMO FISHER SCIENTIFIC

14.8 BRUKER CORPORATION

14.9 ABBOTT

14.10 IMMUNEXPRESS

14.11 RESPONSE BIOMEDICAL

14.12 AXIS-SHIELD DIAGNOSTICS

14.13 CYTOSORBENTS

14.14 MITSUBISHI CHEMICAL EUROPE

14.15 EKF DIAGNOSTICS

14.16 EMERGING PLAYERS

14.16.1 SEEGENE

14.16.2 GENMARK DIAGNOSTICS

14.16.3 BODITECH MED

14.16.4 ALPHA LABORATORIES

14.16.5 ALIFAX S.R.L.

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

15 APPENDIX (Page No. - 178)

15.1 DISCUSSION GUIDE

15.2 KNOWLEDGE STORE: MARKETSANDMARKETS� SUBSCRIPTION PORTAL

15.3 AVAILABLE CUSTOMIZATIONS

15.4 RELATED REPORTS

15.5 AUTHOR DETAILS



LIST OF TABLES (160 Tables)

TABLE 1 SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 2 BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017�2025 (USD MILLION)

TABLE 3 BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017�2025 (USD MILLION)

TABLE 4 BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017�2025 (USD MILLION)

TABLE 5 BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017�2025 (USD MILLION)

TABLE 6 BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017�2025 (USD MILLION)

TABLE 7 BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017�2025 (USD MILLION)

TABLE 8 IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017�2025 (USD MILLION)

TABLE 9 IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017�2025 (USD MILLION)

TABLE 10 IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017�2025 (USD MILLION)

TABLE 11 IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017�2025 (USD MILLION)

TABLE 12 IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017�2025 (USD MILLION)

TABLE 13 IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017�2025 (USD MILLION)

TABLE 14 MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 15 MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017�2025 (USD MILLION)

TABLE 16 MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017�2025 (USD MILLION)

TABLE 17 MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017�2025 (USD MILLION)

TABLE 18 MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017�2025 (USD MILLION)

TABLE 19 MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017�2025 (USD MILLION)

TABLE 20 MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017�2025 (USD MILLION)

TABLE 21 PCR MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017�2025 (USD MILLION)

TABLE 22 PCR MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017�2025 (USD MILLION)

TABLE 23 PCR MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017�2025 (USD MILLION)

TABLE 24 PCR MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017�2025 (USD MILLION)

TABLE 25 PCR MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017�2025 (USD MILLION)

TABLE 26 PCR MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017�2025 (USD MILLION)

TABLE 27 MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017�2025 (USD MILLION)

TABLE 28 MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017�2025 (USD MILLION)

TABLE 29 MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017�2025 (USD MILLION)

TABLE 30 MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017�2025 (USD MILLION)

TABLE 31 MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017�2025 (USD MILLION)

TABLE 32 MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017�2025 (USD MILLION)

TABLE 33 PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017�2025 (USD MILLION)

TABLE 34 PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017�2025 (USD MILLION)

TABLE 35 PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017�2025 (USD MILLION)

TABLE 36 PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017�2025 (USD MILLION)

TABLE 37 PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017�2025 (USD MILLION)

TABLE 38 PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017�2025 (USD MILLION)

TABLE 39 SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017�2025 (USD MILLION)

TABLE 40 SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017�2025 (USD MILLION)

TABLE 41 SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017�2025 (USD MILLION)

TABLE 42 SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017�2025 (USD MILLION)

TABLE 43 SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017�2025 (USD MILLION)

TABLE 44 SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017�2025 (USD MILLION)

TABLE 45 FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017�2025 (USD MILLION)

TABLE 46 FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017�2025 (USD MILLION)

TABLE 47 FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017�2025 (USD MILLION)

TABLE 48 FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017�2025 (USD MILLION)

TABLE 49 FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017�2025 (USD MILLION)

TABLE 50 FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017�2025 (USD MILLION)

TABLE 51 MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017�2025 (USD MILLION)

TABLE 52 MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017�2025 (USD MILLION)

TABLE 53 MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017�2025 (USD MILLION)

TABLE 54 MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017�2025 (USD MILLION)

TABLE 55 MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017�2025 (USD MILLION)

TABLE 56 MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSIS, BY END USER, 2017 � 2025 (USD MILLION)

TABLE 57 BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017�2025 (USD MILLION)

TABLE 58 BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017�2025 (USD MILLION)

TABLE 59 BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017�2025 (USD MILLION)

TABLE 60 BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017�2025 (USD MILLION)

TABLE 61 BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017�2025 (USD MILLION)

TABLE 62 BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017�2025 (USD MILLION)

TABLE 63 SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2017�2025 (USD MILLION)

TABLE 64 SEPSIS DIAGNOSTIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2017�2025 (USD MILLION)

TABLE 65 SEPSIS DIAGNOSTIC ASSAYS & REAGENTS MARKET, BY REGION, 2017�2025 (USD MILLION)

TABLE 66 SEPSIS DIAGNOSTIC INSTRUMENTS MARKET, BY REGION, 2017�2025 (USD MILLION)

TABLE 67 SEPSIS DIAGNOSTIC SOFTWARE MARKET, BY REGION, 2017�2025 (USD MILLION)

TABLE 68 SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2017�2025 (USD MILLION)

TABLE 69 CONVENTIONAL DIAGNOSTICS MARKET, BY REGION, 2017�2025 (USD MILLION)

TABLE 70 AUTOMATED DIAGNOSTICS MARKET, BY REGION, 2017�2025 (USD MILLION)

TABLE 71 SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2017�2025 (USD MILLION)

TABLE 72 BACTERIAL SEPSIS MARKET, BY TYPE, 2017�2025 (USD MILLION)

TABLE 73 BACTERIAL SEPSIS MARKET, BY REGION, 2019�2025 (USD MILLION)

TABLE 74 CAUSES OF ADULT SEPSIS: GRAM-NEGATIVE BACTERIA

TABLE 75 GRAM-NEGATIVE BACTERIAL SEPSIS MARKET, BY REGION, 2019�2025 (USD MILLION)

TABLE 76 CAUSES OF ADULT SEPSIS: GRAM-POSITIVE BACTERIA

TABLE 77 GRAM-POSITIVE BACTERIAL SEPSIS MARKET, BY REGION, 2019�2025 (USD MILLION)

TABLE 78 FUNGAL SEPSIS MARKET, BY REGION, 2019�2025 (USD MILLION)

TABLE 79 OTHER PATHOGENS MARKET, BY REGION, 2017�2025 (USD MILLION)

TABLE 80 SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2017�2025 (USD MILLION)

TABLE 81 LABORATORY SEPSIS DIAGNOSTIC TESTS MARKET, BY REGION, 2017�2025 (USD MILLION)

TABLE 82 POINT-OF-CARE SEPSIS DIAGNOSTIC TESTS MARKET, BY REGION, 2017�2025 (USD MILLION)

TABLE 83 SEPSIS DIAGNOSTICS MARKET, BY END USER, 2017�2025 (USD MILLION)

TABLE 84 SEPSIS DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2017�2025 (USD MILLION)

TABLE 85 SEPSIS DIAGNOSTICS MARKET FOR PATHOLOGY & REFERENCE LABORATORIES, BY REGION, 2017�2025 (USD MILLION)

TABLE 86 SEPSIS DIAGNOSTICS MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2017�2025 (USD MILLION)

TABLE 87 SEPSIS DIAGNOSTICS MARKET, BY REGION, 2017�2025 (USD MILLION)

TABLE 88 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2017�2025 (USD MILLION)

TABLE 89 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 90 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 91 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2017�2025 (USD MILLION)

TABLE 92 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2017�2025 (USD MILLION)

TABLE 93 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2017�2025 (USD MILLION)

TABLE 94 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2017�2025 (USD MILLION)

TABLE 95 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2017�2025 (USD MILLION)

TABLE 96 US: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 97 US: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 98 CANADA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 99 CANADA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 100 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2017�2025 (USD MILLION)

TABLE 101 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 102 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 103 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2017�2025 (USD MILLION)

TABLE 104 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2017�2025 (USD MILLION)

TABLE 105 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2017�2025 (USD MILLION)

TABLE 106 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2017�2025 (USD MILLION)

TABLE 107 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2017�2025 (USD MILLION)

TABLE 108 GERMANY: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 109 GERMANY: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 110 FRANCE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 111 FRANCE: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 112 UK: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 113 UK: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 114 ITALY: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 115 ITALY: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 116 SPAIN: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 117 SPAIN: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 118 REST OF EUROPE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 119 REST OF EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 120 ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2017�2025 (USD MILLION)

TABLE 121 ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 122 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 123 ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2017�2025 (USD MILLION)

TABLE 124 ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2017�2025 (USD MILLION)

TABLE 125 ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2017�2025 (USD MILLION)

TABLE 126 ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2017�2025 (USD MILLION)

TABLE 127 ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2017�2025 (USD MILLION)

TABLE 128 JAPAN: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 129 JAPAN: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 130 CHINA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 131 CHINA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 132 INDIA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 133 INDIA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 134 AUSTRALIA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 135 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 136 SOUTH KOREA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 137 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 138 REST OF ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 139 REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 140 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2017�2025 (USD MILLION)

TABLE 141 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 142 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 143 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2017�2025 (USD MILLION)

TABLE 144 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2017�2025 (USD MILLION)

TABLE 145 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2017�2025 (USD MILLION)

TABLE 146 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2017�2025 (USD MILLION)

TABLE 147 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2017�2025 (USD MILLION)

TABLE 148 BRAZIL: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 149 BRAZIL: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 150 MEXICO: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 151 MEXICO: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 152 REST OF LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 153 REST OF LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 154 MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017�2025 (USD MILLION)

TABLE 155 MIDDLE EAST AND AFRICA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017�2025 (USD MILLION)

TABLE 156 MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2017�2025 (USD MILLION)

TABLE 157 MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2017�2025 (USD MILLION)

TABLE 158 MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2017�2025 (USD MILLION)

TABLE 159 MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2017�2025 (USD MILLION)

TABLE 160 MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2017�2025 (USD MILLION)



LIST OF FIGURES (36 Figures)

FIGURE 1 RESEARCH DESIGN

FIGURE 2 BREAKDOWN OF PRIMARIES: GLOBAL SEPSIS DIAGNOSTICS MARKET

FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING

FIGURE 4 MARKET SIZE ESTIMATION: SEPSIS DIAGNOSTICS MARKET

FIGURE 5 DATA TRIANGULATION METHODOLOGY

FIGURE 6 SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2019 VS 2025

FIGURE 7 SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019 VS 2025

FIGURE 8 SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2019 VS 2025

FIGURE 9 SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019 VS 2025

FIGURE 10 SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2019 VS 2025

FIGURE 11 SEPSIS DIAGNOSTICS MARKET, BY END USER, 2018

FIGURE 12 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY REGION, 2019 (USD MILLION)

FIGURE 13 RISING PREVALENCE OF SEPSIS IS DRIVING DEMAND FOR DIAGNOSTICS

FIGURE 14 BLOOD CULTURE SEGMENT WILL DOMINATE THE MARKET DURING 2019�2025

FIGURE 15 BLOOD CULTURE MEDIA SEGMENT TO DOMINATE THE GLOBAL SEPSIS DIAGNOSTICS PRODUCTS MARKET IN 2019

FIGURE 16 HOSPITALS SEGMENT TO DOMINATE THE ASIA PACIFIC MARKET DURING THE FORECAST PERIOD

FIGURE 17 GRAM-NEGATIVE BACTERIAL SEPSIS HOLDS LARGEST SHARE OF THE GLOBAL MARKET, BY PATHOGEN

FIGURE 18 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

FIGURE 19 SEPSIS DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES

FIGURE 20 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET SNAPSHOT

FIGURE 21 APAC: SEPSIS DIAGNOSTICS MARKET SNAPSHOT

FIGURE 22 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE SEPSIS DIAGNOSTICS MARKET, 2016�2019

FIGURE 23 SEPSIS DIAGNOSTICS MARKET SHARE, BY KEY PLAYERS, 2018

FIGURE 24 SEPSIS DIAGNOSTICS MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019

FIGURE 25 BIOM�RIEUX: COMPANY SNAPSHOT

FIGURE 26 BD: COMPANY SNAPSHOT

FIGURE 27 DANAHER: COMPANY SNAPSHOT

FIGURE 28 T2 BIOSYSTEMS: COMPANY SNAPSHOT (2019)

FIGURE 29 LUMINEX: COMPANY SNAPSHOT

FIGURE 30 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT

FIGURE 31 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

FIGURE 32 BRUKER: COMPANY SNAPSHOT

FIGURE 33 ABBOTT: COMPANY SNAPSHOT

FIGURE 34 CYTOSORBENTS: COMPANY SNAPSHOT

FIGURE 35 MITSUBISHI CHEMICAL EUROPE: COMPANY SNAPSHOT

FIGURE 36 EKF DIAGNOSTICS: COMPANY SNAPSHOT